Bio-Rad Laboratories (BIO) Capital Expenditures (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Capital Expenditures of $30.0 million for Q1 2026, down 12.79% year-over-year from $34.4 million in Q1 2025, and down 34.5% quarter-over-quarter from $45.8 million in Q4 2025.
Bio-Rad Laboratories (BIO) Capital Expenditures (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Capital Expenditures for 18 consecutive years, with $30.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 12.79% year-over-year to $30.0 million; the TTM figure through Mar 2026 stood at $153.2 million (down 4.13% YoY), while the FY2025 annual figure was $157.6 million, down 4.83% from the prior year.
- Capital Expenditures fell to $30.0 million in Q1 2026 per BIO's latest filing, from $45.8 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $45.8 million in Q4 2025 and bottomed at $17.3 million in Q2 2022.
- Historically, Capital Expenditures has averaged $36.6 million across 5 years, with a median of $35.7 million in 2023.
- Annual changes were most pronounced in 2022 — Capital Expenditures plunged 38.04% — and 2023, when it jumped 99.83%.
- Bio-Rad Laboratories' Capital Expenditures stood at $34.8 million in 2022, then climbed by 21.41% to $42.3 million in 2023, then increased by 1.5% to $42.9 million in 2024, then advanced by 6.76% to $45.8 million in 2025, then slumped by 34.5% to $30.0 million in 2026.
- Business Quant data shows BIO's Capital Expenditures at $30.0 million in Q1 2026, $45.8 million in Q4 2025, and $31.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | 32.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.00 Mn |
| Jun 30, 2026 | 32.00 Mn |
| Mar 31, 2026 | 30.00 Mn |
| Mar 31, 2026 | 30.00 Mn |
| Dec 31, 2025 | 45.80 Mn |
| Dec 31, 2025 | 45.80 Mn |
| Sep 30, 2025 | 31.70 Mn |
| Sep 30, 2025 | 31.70 Mn |
| Jun 30, 2025 | 45.70 Mn |
| Jun 30, 2025 | 45.70 Mn |
| Mar 31, 2025 | 34.40 Mn |
| Mar 31, 2025 | 34.40 Mn |
| Dec 31, 2024 | 42.90 Mn |
| Dec 31, 2024 | 42.90 Mn |
| Sep 30, 2024 | 40.20 Mn |
| Sep 30, 2024 | 40.20 Mn |
| Jun 30, 2024 | 42.30 Mn |
| Jun 30, 2024 | 42.30 Mn |
| Mar 31, 2024 | 40.20 Mn |
| Mar 31, 2024 | 40.20 Mn |